Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose
William A. Werbel(Johns Hopkins University), Dorry L. Segev(New York University), William Clarke(Johns Hopkins University), Tao Liang(Johns Hopkins University), Robin K. Avery(Johns Hopkins University), Christine M. Durand(University of Maryland, Baltimore), Maria Bettinotti(Johns Hopkins University), Nancy D. Bridges(National Institute of Allergy and Infectious Diseases), Teresa Po‐Yu Chiang(Johns Hopkins University), Allan B. Massie(Johns Hopkins University), Natasha Watson(ETH Zurich), Elizabeth A. Thompson(North Carolina State University), Ioannis Sitaras(Johns Hopkins University), Sabra L. Klein(Johns Hopkins University), Nadine Rouphael(Emory University), Hady Samaha(Emory University), Daniel Warren(Johns Hopkins University), M. Chahoud(Johns Hopkins University), Aileen C. Johnson(Emory University), Diane Brown(Johns Hopkins University), Christian P. Larsen(Emory University Hospital), Andrew Pekosz(Johns Hopkins University), Aaron A.R. Tobian(Johns Hopkins University), Andrew H. Karaba(Johns Hopkins University), Willa Cochran(Johns Hopkins Hospital), Peter S. Heeger(Cedars-Sinai Medical Center), Andrea L. Cox(Johns Hopkins University), Justin R. Bailey(Johns Hopkins University), Christopher Huerta(Emory University), Miguel Fribourg(Icahn School of Medicine at Mount Sinai)
Cited by 19
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
Impact of sex and gender on COVID-19 outcomes in Europe
|Biology of Sex Differences|2020|1.4k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k